Bio-Techne (TECH) Payables (2010 - 2026)

Bio-Techne's Payables history runs 17 years deep, the most recent figure standing at $23.5 million for Q1 2026.

• On a quarterly basis, Payables fell 25.77% year-over-year to $23.5 million in Q1 2026; TTM through Mar 2026 was $23.5 million, a 25.77% decrease from a year earlier, with the FY2025 full-year figure at $25.3 million, down 33.34% from the prior year.
• Payables retreated to $23.5 million in Q1 2026 per TECH's latest filing, from $26.3 million in the prior quarter.
• Across five years, Payables topped out at $38.0 million in Q2 2024 and bottomed at $23.5 million in Q1 2026.
• The 5-year median for Payables is $30.2 million (2025), against an average of $29.6 million.
• Across the five-year window, Payables jumped 47.86% in 2024 and slumped 33.34% in 2025, its largest moves.
• Year by year, Payables stood at $24.1 million in 2022, then surged by 30.76% to $31.5 million in 2023, then advanced by 5.1% to $33.1 million in 2024, then declined by 20.69% to $26.3 million in 2025, then slipped by 10.58% to $23.5 million in 2026.
• Per Business Quant, the three latest TECH Payables figures stand at $23.5 million (Q1 2026), $26.3 million (Q4 2025), and $30.2 million (Q3 2025).